377 related articles for article (PubMed ID: 24033967)
1. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
[TBL] [Abstract][Full Text] [Related]
2. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
[TBL] [Abstract][Full Text] [Related]
4. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
[TBL] [Abstract][Full Text] [Related]
5. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.
Shen B; Zheng MQ; Lu JW; Jiang Q; Wang TH; Huang XE
Asian Pac J Cancer Prev; 2013; 14(9):5403-8. PubMed ID: 24175834
[TBL] [Abstract][Full Text] [Related]
7. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
9. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer.
Lee HJ; Jo DY
Histol Histopathol; 2012 Sep; 27(9):1155-61. PubMed ID: 22806902
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review.
Bocchi M; de Sousa Pereira N; de Oliveira KB; Amarante MK
Mol Biol Rep; 2023 Jul; 50(7):6233-6239. PubMed ID: 37219666
[TBL] [Abstract][Full Text] [Related]
11. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.
Sleightholm RL; Neilsen BK; Li J; Steele MM; Singh RK; Hollingsworth MA; Oupicky D
Pharmacol Ther; 2017 Nov; 179():158-170. PubMed ID: 28549596
[TBL] [Abstract][Full Text] [Related]
13. CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor κB: implications for bidirectional tumor-stromal interactions.
Singh AP; Arora S; Bhardwaj A; Srivastava SK; Kadakia MP; Wang B; Grizzle WE; Owen LB; Singh S
J Biol Chem; 2012 Nov; 287(46):39115-24. PubMed ID: 22995914
[TBL] [Abstract][Full Text] [Related]
14. Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells.
Ren L; Liu YQ; Zhou WH; Zhang YZ
Hum Reprod; 2012 Feb; 27(2):366-74. PubMed ID: 22114110
[TBL] [Abstract][Full Text] [Related]
15. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
16. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
[TBL] [Abstract][Full Text] [Related]
17. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling.
Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X
Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and cancer.
Furusato B; Mohamed A; Uhlén M; Rhim JS
Pathol Int; 2010 Jul; 60(7):497-505. PubMed ID: 20594270
[TBL] [Abstract][Full Text] [Related]
19. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
Mitchell B; Mahalingam M
Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
[TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
